ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Nuo Therapeutics Inc (QB)

Nuo Therapeutics Inc (QB) (AURX)

1,01
0,00
(0,00%)
Fermé 03 Juillet 10:00PM

Nuo Therapeutics Inc (QB) (AURX) Opérations d'Initiés

-
Filtrer par:
Date Nom du détenteur Actions transigées Fourchette de valeur ($) Type d'opération Fourchette de prix ($) Actions en fin de déclaration % de variation
2026-01-01Mr. David E. JordenCEO, CFO, Secretary & Executive Director99,62k39,85kDerivative Exercise and Retained Stock0,402,05M5,12%
2026-01-01Mr. David E. JordenCEO, CFO, Secretary & Executive Director-25,38k39,85kDerivative Exercise and Sale0,40 - 1,972,05M-
2025-12-17Mr. C. Eric WinzerIndependent Director55,00k22,00kDerivative Exercise and Retained Stock0,40172,65k46,75%
2025-12-17Mr. C. Eric WinzerIndependent Director-13,75k22,00kDerivative Exercise and Sale0,40 - 2,00172,65k-
2025-12-09Prof. Paul David MintzIndependent Director40,91k16,36kDerivative Exercise and Retained Stock0,40108,29k60,71%
2025-12-09Prof. Paul David MintzIndependent Director-9,09k16,36kDerivative Exercise and Sale0,40 - 2,20108,29k-
2025-11-28Mr. David E. JordenCEO, CFO, Secretary & Executive Director-200,00k300,00kVente1,501,95M-9,32%
2025-08-01Mr. C. Eric WinzerIndependent Director92,65k37,06kDerivative Exercise and Retained Stock0,40117,65k370,62%
2025-08-01Mr. C. Eric WinzerIndependent Director-27,66k37,06kDerivative Exercise and Sale0,40 - 1,74117,65k-
2025-08-01Prof. Paul David MintzIndependent Director67,39k26,95kDerivative Exercise and Retained Stock0,4067,39k-
2025-08-01Prof. Paul David MintzIndependent Director-20,12k26,95kDerivative Exercise and Sale0,40 - 1,7467,39k-
2025-08-01Mr. David E. JordenCEO, CFO, Secretary & Executive Director171,40k68,56kDerivative Exercise and Retained Stock0,402,15M8,68%
2025-08-01Mr. David E. JordenCEO, CFO, Secretary & Executive Director-21,31k28,56kDerivative Exercise and Sale0,40 - 1,742,15M-
2025-07-31Dr. Peter Anton ClausenCOO & Chief Scientific Officer183,85k73,54kDerivative Exercise and Retained Stock0,40773,53k31,18%
2025-07-30Mr. Charles Edmund SheedyInitié133,33k200,00kAchat1,5011,57M1,17%